About Regenosca

Regenosca provides regenerative medicine technology that enables permanent regrowth of your own native tissues on a self-absorbing mesh, ensuring seamless healing of soft tissue defects and surgical wounds. Our solutions are designed with surgeons in mind.

While not a living tissue, Regenosca’s TissueSpan mesh is engineered to actively attract and organize the patient’s own cells upon implantation, initiating the body’s natural regenerative processes. Fully absorbable, off-the-shelf, and ready-to-use, TissueSpan ensures easy clinical translation and compatibility with current surgical techniques. Early clinical data in urethral stricture repair have demonstrated that TissueSpan is safe and effective, leading to successful tissue healing and providing a reliable, cutting-edge solution for enhancing the post operative recovery of patients. Additionally, it can be manufactured in various shapes to accommodate a wide range of clinical indications, providing a versatile and reliable solution for surgical practice.

“Our goal is to become the number one solution for the reconstructive urology market, whilst building solutions for adjacent indications.”

Collaboration within the SFITS Startup Accelerator Program

This partnership offers Regenosca invaluable access to leading medical experts in urology and other specialties. It is crucial in ensuring that TissueSpan meshes are fully compatible with a wide range of surgical techniques and in developing efficient clinical trial protocols. Furthermore, the SFITS supports them with their extensive network, which includes potential manufacturing facilities, resources for proving the concept of various TissueSpan mesh applications, and pathways to bring TissueSpan to the next generation of patients. Finally, the SFITS will introduce them to potential strategic partners from the industry, expanding opportunities for collaboration and growth.

More about the Startup Program.

Photo gallery